This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to DR Reddy's Laboratories, Inc., a multinational pharmaceutical manufacturer. The contract has a base year from November 26, 2022 to November 25, 2023, with four one-year option periods, for a total ceiling value of $7,616,074.14.
The contract is for the supply of four line items of chlorthalidone tablets in 25mg and 50mg sizes, to be distributed through the VA and Department of Defense (DoD) Pharmaceutical Prime Vendor programs. The estimated annual requirement ranges from 2,500 to 113,457 bottles across the different chlorthalidone tablet products. This indefinite delivery contract aims to provide an uninterrupted supply of these essential pharmaceutical items to support the healthcare missions of the VA, DoD, Bureau of Prisons, and Indian Health Service. DR Reddy's Laboratories holds multiple IDCs and Federal Supply Schedule contracts with the VA to supply a range of generic prescription drugs and over-the-counter medications to federal government agencies.
Generated 11/19/24, 9:06 AM